Cerebrovascular pulsatility index is higher in chronic kidney disease

Ester S Oh1, Kaitlin A Freeberg2, Cortney N Steele1

  • 1Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Physiological Reports
|January 13, 2023
PubMed

Insights

Patients with chronic kidney disease (CKD) show increased cerebrovascular stiffness, a potential contributor to cognitive decline. This study found higher middle cerebral artery pulsatility index in CKD patients, linking impaired kidney function to brain blood vessel health.

Area of Science:

  • Nephrology
  • Neurology
  • Cardiovascular Science

Background:

  • Patients with chronic kidney disease (CKD) face higher risks of cardiovascular diseases than kidney failure.
  • Cerebrovascular dysfunction, including reduced reactivity and hypoperfusion, is linked to cognitive impairment and dementia.
  • The presence of cerebrovascular dysfunction in non-dialysis CKD patients remains largely uncharacterized.

Purpose of the Study:

  • To investigate cerebrovascular function in patients with stage 3-4 CKD compared to healthy controls.
  • To assess cerebrovascular reactivity and stiffness in relation to kidney function and cognitive status.

Main Methods:

  • Transcranial Doppler ultrasound measured middle cerebral artery (MCA) blood velocity response to hypercapnia and MCA pulsatility index (PI).
  • Cognitive function was assessed using the NIH cognitive toolbox.
  • Aortic stiffness (carotid-femoral pulse-wave velocity) and ex vivo nitric oxide/reactive oxygen species production were measured.

Main Results:

  • Patients with CKD exhibited a higher MCA pulsatility index (cerebrovascular stiffness) than controls.
  • Normalized MCA blood velocity response to hypercapnia did not differ between groups.
  • MCA PI correlated with increased aortic stiffness, poorer executive function, lower estimated glomerular filtration rate (eGFR), and higher reactive oxygen species production.

Conclusions:

  • Impaired kidney function in CKD is associated with increased cerebrovascular stiffness.
  • Cerebrovascular stiffness may be a key mechanism contributing to cognitive impairment in CKD patients.
  • These findings highlight the link between kidney disease, vascular health, and brain function.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
59
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
54
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
48
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
24
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
56